Brain-targeted drug and gene delivery by intranasal administration
-
- Kanazawa Takanori
- Lab. of Pharmaceutical Technology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
-
- Takashima Yuuki
- Lab. of Pharmaceutical Technology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
Bibliographic Information
- Other Title
-
- 高分子ミセルをキャリアとする経鼻投与による脳への薬物・核酸デリバリー
- コウブンシ ミセル オ キャリア ト スル ケイ ビ トウヨ ニ ヨル ノウ エ ノ ヤクブツ ・ カクサン デリバリー
Search this article
Description
Intranasal administration is a promising effective and non-invasive drug delivery to the brain without passing through the blood-brain barrier (BBB). Cell penetrating peptide-modified block copolymer micelles (MPEG-PCL-Tat) have potential for improvement of mucosal permeability and nose-to-brain transport efficiency. Here we review the advantages of our MPEG-PCL-Tat micelles for intranasal drug and gene delivery.
Journal
-
- Drug Delivery System
-
Drug Delivery System 28 (4), 318-327, 2013
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204641465088
-
- NII Article ID
- 130003384382
-
- NII Book ID
- AN10084591
-
- COI
- 1:CAS:528:DC%2BC3sXhvVagur%2FL
-
- ISSN
- 18812732
- 09135006
-
- NDL BIB ID
- 024902465
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed